Clinical Trials Directory

Trials / Completed

CompletedNCT07150273

A Clinical Study to Evaluate the Efficacy and Safety of the Injection With UNIVELO Sub-Q, as Compared to Restylane® Sub-Q, in the Temporary Correction of the Nasolabial Fold

A Randomized, Single-Center, Patient & Evaluator-Blind, Matched Pairs, Active-Controlled Design Confirmatory Clinical Study to Evaluate the Efficacy and Safety of the Injection With UNIVELO Sub-Q, as Compared to Restylane® Sub-Q, in the Temporary Correction of the Nasolabial Fold

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Jetema Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

A 48-week, single-center, randomized, patient \& evaluator-blind, matched pairs, active-controlled, non-inferiority, confirmatory design

Conditions

Interventions

TypeNameDescription
DEVICEUNIVELO Sub-Q 2mLTest device
DEVICERestylane Sub-Q 2mLComparator Device

Timeline

Start date
2016-02-23
Primary completion
2017-03-23
Completion
2017-07-28
First posted
2025-09-02
Last updated
2025-09-08

Source: ClinicalTrials.gov record NCT07150273. Inclusion in this directory is not an endorsement.